Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

A common polymorphism in the interleukin-6 gene promoter is associated with overweight

Abstract

OBJECTIVE: Human body fat mass is to a large extent genetically determined, but little is known about the susceptibility genes for common obesity. Interleukin-6 (IL-6) suppresses body fat mass in rodents, and IL-6 treatment increases energy expenditure in both rodents and humans. The −174 G/C single-nucleotide polymorphism (SNP) in the IL-6 gene promoter is common in many populations, and −174 C-containing promoters have been found to be weaker enhancers of transcription. Moreover, a SNP at position −572 in the IL-6 promoter has recently been reported to affect transcription. The objective was to investigate the association between the IL-6 gene promoter SNPs and obesity.

DESIGN: Trans-sectional association study of IL-6 gene promoter SNPs and indices of obesity.

SUBJECTS: Two study populations, the larger one consisting of hypertensive individuals (mean age 57 y, 73% males, n=485) and the other consisting of 20 y younger nonobese healthy females (n=74).

MEASUREMENTS: Genotyping for the −174 IL-6 G/C and the −572 G/C SNPs, body mass index (BMI), serum leptin levels, serum IL-6 levels, C-reactive protein, fasting blood glucose and various blood lipids.

RESULTS: The common −174 C allele (fC=0.46), but not any −572 allele, was associated with higher BMI and higher serum leptin levels in both study populations. In the larger population, there were significant odds ratios for the association of CC (2.13) and GC (1.76) genotypes with overweight (BMI>25 kg/m2). Moreover, as the C allele was common, it accounted for a significant population-attributable risk of overweight (12%; CI 2–21%), although its average effect was modest in this sample.

CONCLUSION: Genetically determined individual differences in production of IL-6 may be relevant for the regulation of body fat mass.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Barsh GS, Farooqi IS, O'Rahilly S . Genetics of body-weight regulation. Nature 2000; 404: 644–651.

    Article  CAS  PubMed  Google Scholar 

  2. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE . The body-mass index of twins who have been reared apart. N Engl J Med 1990; 322: 1483–1487.

    Article  CAS  PubMed  Google Scholar 

  3. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P . Melanocortin-4 receptor mutations are a frequent, heterogeneous cause of morbid obesity. J Clin Invest 2000; 106: 253–262.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S . Clinical spectrum of obesity, mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085–1095.

    Article  CAS  PubMed  Google Scholar 

  5. Butler AA, Cone RD . Knockout models resulting in the development of obesity. Trends Genet 2001; 17: S50–S54.

    Article  CAS  PubMed  Google Scholar 

  6. Wallenius V, Wallenius K, Ahrén B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson J-O . Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002; 8: 75–79.

    Article  CAS  PubMed  Google Scholar 

  7. Wallenius K, Wallenius VW, Sunter D, Dickson SL, Jansson J-O . Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Comm 2002; 293: 560–565.

    Article  CAS  PubMed  Google Scholar 

  8. Li G, Klein RL, Matheny M, King MA, Meyer EM, Scarpace PJ . Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue, underlies one mechanism of body weight reduction in rats. Neuroscience 2002; 115: 879–889.

    Article  CAS  PubMed  Google Scholar 

  9. Hirano T . Interleukin 6, its receptor: ten years later. Int Rev Immunol 1998; 16: 249–284.

    Article  CAS  PubMed  Google Scholar 

  10. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ . The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease, systolic blood pressure in healthy men. Eur Heart J 2001; 22: 2243–2252.

    Article  CAS  PubMed  Google Scholar 

  11. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P . The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369–1376.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Terry CF, Loukaci V, Green FR . Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275: 18138–18144.

    Article  CAS  PubMed  Google Scholar 

  13. Rivera-Chavez FA, Peters-Hybki DL, Barber RC, O'Keefe GE . Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock 2003; 20: 218–223.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, Auffarth GU, Grau AJ, Green FR, Grond-Ginsbach C, Schwaninger M . Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 2003; 34: 1864–1869.

    Article  CAS  PubMed  Google Scholar 

  15. Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL . Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 2003; 88: 255–259.

    Article  CAS  PubMed  Google Scholar 

  16. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmaki K, Dahlof B, de Faire U, Morlin C, Karlberg BE, Wester PO, Bjorck JE . Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353: 611–616.

    Article  CAS  PubMed  Google Scholar 

  17. Prince JA, Feuk L, Howell WM, Jobs M, Emahazion T, Blennow K, Brookes AJ . Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. Genome Res 2001; 11: 152–162.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Fernandez-Real JM, Broch M, Vendrell J, Richart C, Ricart W . Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects (see comments). J Clin Endocrinol Metab 2000; 85: 1334–1339.

    Article  CAS  PubMed  Google Scholar 

  19. Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F, Ladurner G, Hell E, Strosberg AD, Patsch JR, Krempler F, Patsch W . A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 2001; 28: 178–183.

    Article  CAS  PubMed  Google Scholar 

  20. Blom G . Statistical estimates and transformed beta variables. John Wiley & Sons Inc.: New York; 1958.

    Google Scholar 

  21. Geigy JRB . S.A. Geigy scientific tables. Ciba-Geigy Limited: Basle; 1982.

    Google Scholar 

  22. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT . The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997; 82: 1293–1300.

    CAS  PubMed  Google Scholar 

  23. Kazumi T, Kawaguchi A, Hirano T, Yoshino G . C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metabolism 2003; 52: 1113–1116.

    Article  CAS  PubMed  Google Scholar 

  24. Rexrode KM, Pradhan A, Manson JE, Buring JE, Ridker PM . Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol 2003; 13: 674–682.

    Article  PubMed  Google Scholar 

  25. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW . Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196–4200.

    CAS  PubMed  Google Scholar 

  26. Rothwell NJ, Busbridge NJ, Lefeuvre RA, Hardwick AJ, Gauldie J, Hopkins SJ . Interleukin-6 is a centrally acting endogenous pyrogen in the rat. Can J Physiol Pharmacol 1991; 69: 1465–1469.

    Article  CAS  PubMed  Google Scholar 

  27. Tsigos C, Papanicolaou DA, Kyrou I, Defensor R, Mitsiadis CS, Chrousos GP . Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab 1997; 82: 4167–4170.

    Article  CAS  PubMed  Google Scholar 

  28. Stouthard JM, Romijn JA, Van der Poll T, Endert E, Klein S, Bakker PJ, Veenhof CH, Sauerwein HP . Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 1995; 268: E813–E819.

    CAS  PubMed  Google Scholar 

  29. Lyngso D, Simonsen L, Bulow J . Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol 2002; 543: 379–386.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Faldt J, Wernstedt I, Fitzgerald SM, Wallenius K, Bergstrom G, Jansson JO . Reduced exercise endurance in interleukin-6 deficient mice. Endocrinology 2004; 145: 2680–2686.

    Article  PubMed  Google Scholar 

  31. Kubaszek A, Pihlajamaki J, Punnonen K, Karhapaa P, Vauhkonen I, Laakso M . The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 2003; 52: 558–561.

    Article  CAS  PubMed  Google Scholar 

  32. Georges JL, Loukaci V, Poirier O, Evans A, Luc G, Arveiler D, Ruidavets JB, Cambien F, Tiret L . Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Mol Med 2001; 79: 300–305.

    Article  CAS  PubMed  Google Scholar 

  33. Burzotta F, Iacoviello L, Di Castelnuovo A, Glieca F, Luciani N, Zamparelli R, Schiavello R, Donati MB, Maseri A, Possati G, Andreotti F . Relation of the −174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. Am J Cardiol 2001; 88: 1125–1128.

    Article  CAS  PubMed  Google Scholar 

  34. Villuendas G, San Millan JL, Sancho J, Escobar-Morreale HF . The −597 G–>A and −174 G–>C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. J Clin Endocrinol Metab 2002; 87: 1134–1141.

    CAS  PubMed  Google Scholar 

  35. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries SE . Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001; 21: 1458–1463.

    Article  CAS  PubMed  Google Scholar 

  36. Nagaraju K, Raben N, Merritt G, Loeffler L, Kirk K, Plotz P . A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol 1998; 113: 407–414.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Sothern RB, Roitman-Johnson B, Kanabrocki EL, Yager JG, Roodell MM, Weatherbee JA, Young MR, Nenchausky BM, Scheving LE . Circadian characteristics of circulating interleukin-6 in men. J Allergy Clin Immunol 1995; 95: 1029–1035.

    Article  CAS  PubMed  Google Scholar 

  38. Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, Trussell R, Jebb SA, Lip GY, O'Rahilly S . Partial leptin deficiency and human adiposity. Nature 2001; 414: 34–35.

    Article  CAS  PubMed  Google Scholar 

  39. Flier JS . Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004; 116: 337–350.

    Article  CAS  PubMed  Google Scholar 

  40. Stenlof K, Wernstedt I, Fjallman T, Wallenius V, Wallenius K, Jansson JO . Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. J Clin Endocrinol Metab 2003; 88: 4379–4383.

    Article  PubMed  Google Scholar 

  41. Fernandez-Real JM, Ricart W . Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278–301.

    Article  CAS  PubMed  Google Scholar 

  42. Steensberg A, Fischer CP, Sacchetti M, Keller C, Osada T, Schjerling P, van Hall G, Febbraio MA, Pedersen BK . Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. J Physiol 2003; 548: 631–638.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshigawara K, Jin S, Iguchi H, Hiramatsu R, LeRoith D, Takeda K, Akira S, Kasuga M . Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med 2004; 10: 168–174.

    Article  CAS  PubMed  Google Scholar 

  44. Nishimoto N, Yoshizaki K, Maeda K, Kuritani T, Deguchi H, Sato B, Imai N, Suemura M, Kakehi T, Takagi N, Kishimoto T . Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study. J Rheumatol 2003; 30: 1426–1435.

    CAS  PubMed  Google Scholar 

  45. Cooper DN, Nussbaum RL, Krawczak M . Proposed guidelines for papers describing DNA polymorphism-disease associations. Hum Genet 2002; 110: 207–208.

    Article  CAS  PubMed  Google Scholar 

  46. Berthier MT, Paradis AM, Tchernof A, Bergeron J, Prud'homme D, Despres JP, Vohl MC . The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet 2003; 48: 14–19.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

C Uggla, M Peterson and A-L Jirestedt are acknowledged for excellent technical work and suggestions. We also thank Gunnar Ekeroth for invaluable statistical advice and Professor Peter Arner for valid suggestions. This work was supported by grants from the Swedish Research Council (9894), the Swedish Medical Society, the Swedish Society for Medical Research, Vastra Gotaland Foundation, the Novo-Nordisk Foundation, the European Commission (Framework 6, Contract No. LSHM-CT-2003–503041) and the foundations of Bergwall, Thuring and Wiberg.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J-O Jansson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wernstedt, I., Eriksson, AL., Berndtsson, A. et al. A common polymorphism in the interleukin-6 gene promoter is associated with overweight. Int J Obes 28, 1272–1279 (2004). https://doi.org/10.1038/sj.ijo.0802763

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802763

Keywords

This article is cited by

Search

Quick links